CDSCO monthly lab alert
CDSCO NSQ alert, July 2026: 239 drug batches flagged
By Blacklisted editorial team· Published 20 Aug 2026· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its July 2026 alert, the Central Drugs Standard Control Organisation listed 239 drug batches that failed quality tests, 40 at central laboratories and 199 at state drug-testing laboratories, from 198 manufacturers across 165 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Ferrous Ascorbate & Folic Acid Tablets IP, Amoxycillin & Potassium Clavulanate Tablets IP, Telmisartan Tablets IP 40 mg.
239
Batches flagged
40 / 199
Central / state labs
Assay
Top reason
198
Manufacturers
Batches per month, last 12 alerts
Aug 2025Jul 2026 · 239
Full list of NSQ batches, July 2026
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| ketoconazole, Chloridexidine Glueconate & Cetrinide Shampoo | Batch L047D25Mfg Apr 2025 · Exp Mar 2027 | Disinfecto Chemical Industrial Pvt. Ltd. D-7Uttar Pradesh | Assay for chlorhexidine Gluconate onlyAssay | RDTL. Bellary KarnatakaState lab |
| ZEDCORIL EXPECTORANT | Batch 0064Mfg Apr 2026 · Exp Mar 2029 | Lexine Technochem Pvt. LtdGujarat | Content of SalbutamolOther | FDL, VadodaraState lab |
| Vitamin A, Vitamin D3, Vitamin B1 and Niacinamide Tablets | Batch CBT-0178Mfg Sep 2025 · Exp Feb 2027 | Crossasia Biotech Pvt. Ltd | The sample does not conform to Manufacturer's specification with respect to Assay of Vitamin A (Acetate) and Vitamin B1Assay | CDL, KolkataCDSCO lab |
| Triprolidine Hydrochloride & Codeine Phosphate Syrup, 100 ml | Batch L-221226Mfg Nov 2025 · Exp Oct 2027 | BDC Pharmaceuticals 272 | Content of Triprolidine Hydrochloride & Codeine PhosphateOther | Lucknow LabState lab |
| Triamcinolone Acetonide Injection IP (40mg/ml) (1ml) | Batch NPK0260Mfg Dec 2024 · Exp Nov 2027 | Nitin Life Sciences Ltd. Rampur RoadHimachal Pradesh | AssayAssay | Lucknow LabState lab |
| Tranexamic Acid Injection IP | Batch TRI2502Mfg Feb 2026 · Exp Jan 2028 | Blitz Pharmaceuticals Pvt. Ltd | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for the reason stated under DescriptionDescription | CDL, KolkataCDSCO lab |
| Tolperisone & Paracetamol Tablets | Batch TB26.084Mfg Feb 2026 · Exp Jan 2028 | Verax Life Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to label claim with respect to content of Tolperisone HydrochlorideLabelling | Drugs Testing Laboratory, Madurai-19State lab |
| Terbinafine Hydrochloride Tablets IP 250mg | Batch AT25110990AMfg Nov 2025 · Exp Oct 2027 | Accura Care Pharmaceuticals Pvt. LtdHimachal Pradesh | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 40mg | Batch STS-114Mfg May 2025 · Exp Apr 2027 | Marc Lifesciences SikkimSikkim | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 40 mg | Batch 493TTF004Mfg Jul 2025 · Exp Jun 2027 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards. If fails the test Dissolution as per IPDissolution | DTL, TVPMState lab |
| Telmisartan Tablets IP 40 mg | Batch 493TTF014Mfg Aug 2025 · Exp Jul 2027 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards. It fails the test Dissolution as per IPDissolution | DTL, TVPMState lab |
| Telmisartan Tablets IP 40 mg | Batch CT25624Mfg Dec 2025 · Exp Nov 2027 | Century Nova Drugs Pvt. Ltd | The Sample does not Comply for Description as the Tablets shows uneven Light Brown coloured Spots all over the Surface of the TabletsDescription | FDAL, Chhatrapati SambhajinagarState lab |
| Telmisartan Tablets IP 20 mg | Batch HT250167Mfg Aug 2025 · Exp Jul 2027 | MEDICAMEN Biotech LtdUttarakhand | The sample received does not conform to the I.P. 2022 standard with respect to the test for Dissolution.Dissolution | CDTL, MumbaiCDSCO lab |
| Telmisartan & Hydrochlorothiazide Tablets IP | Batch AMT-2460Mfg Nov 2025 · Exp Oct 2027 | Avalon Medicines Pvt. LtdHaryana | The sample received does not conform to i.p. 2022 specification with respect to the test for Dissolution of hydrochlorothiazide only.Dissolution | CDTL, HyderabadCDSCO lab |
| Telmisartan & Amlodipine Tablets I.P. | Batch 2510095Mfg Oct 2025 · Exp Sep 2027 | Sai sarvaa Biotech Pvt. Ltd | 01. ASSAY OF AMLODIPINE I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Tapentadol Hydrochloride Tablets | Batch T087J44Mfg Jan 2026 · Exp Dec 2027 | Biomax Biotechnics (P) LtdHaryana | The sample does not conforms to the claim with respect to Assay.Assay | DTL BikanerState lab |
| Spasmore (Acetaminophen, Tramadol HCl & Dicyclomine HCl Capsules). | Batch SE026040Mfg Apr 2026 · Exp Mar 2028 | Danish Health Care (P) Ltd | 01. ASSAY OF TRAMADOL HCL I.P. & DICYCLOMINE HCL I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Soflgel Capsules Ferrous ascorbate Folic Acid &Zinc Soft Getatin Capsules | Batch CD-251244BMfg Jan 2025 · Exp May 2027 | Capsoft Healthcare Pvt. LtdHimachal Pradesh | Description & Disintegration test "and does not conform to label claim with respect to " Assay for folic AcidAssay | RDTL. Bellary KarnatakaState lab |
| Sodium chloride injection IP 0.9% w/v | Batch (N)25567Mfg Nov 2025 · Exp Oct 2027 | klokter Lifesciences private Ltd | Fail in AssayAssay | DTL, BaddiState lab |
| Sodium chloride injection IP 0.9% w/v | Batch (N)25479Mfg Sep 2025 · Exp Aug 2027 | klokter Lifesciences private Ltd | Fail in AssayAssay | DTL, BaddiState lab |
| Sodium Chloride Injection IP 0.9%w/v | Batch G2604H025Mfg May 2026 · Exp Apr 2028 | MKA Remedies Pvt. Ltd | The sample does not conforms to I.P. 2022 with respect to the test for Particulate contamination.Particulate matter | CDTL, MumbaiCDSCO lab |
| Sodium Bicarbonate Tablets I.P. 1000 mg | Batch T-2509202Mfg Sep 2025 · Exp Aug 2027 | Rivpra Formulation Pvt. LtdUttarakhand | The sample does not conform to I.P (Addendum 2024) with respect to the Test of DisintegrationDisintegration | CDTL, IndoreCDSCO lab |
| Sodium Bicarbonat Tablets USP 500mg | Batch 25087Mfg Nov 2025 · Exp Oct 2027 | Steadfast edishield Pvt. LtdUttarakhand | MisbrandingMisbranded | SDTL, RaipurState lab |
| Roller Bandage Non Sterilized | Batch RC13Mfg Dec 2025 · Exp Nov 2028 | Mohan Pharma B-5/2Telangana | The Sample Does not conform to schedule F-II with respect to Description, Threads per dm (Warp) Length & Width.Description | DCL, TelanganaState lab |
| Ramipril Tablets IP 5mg | Batch R25183701KMfg Nov 2025 · Exp Oct 2027 | Reltsen Health CarePuducherry | Ramipril (64.20%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Racecadotril Capsules IP 100mg, | Batch C042604Mfg Apr 2026 · Exp Mar 2028 | Swefn Pharmaceuticals Pvt. LtdGujarat | The sample does not conform to claim as per IP 2022 in respect to Assay of Racecadotril.Assay | RDTL, ChandigarhCDSCO lab |
| Rabeprazole Sodium Injection I.P. 20 mg/vial | Batch MD24K17Mfg Nov 2024 · Exp Oct 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. with respect to the Description, pH, Clarity of solution, Particulate matter and Assay of Rabeprazole SodiumAssay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Gastro-Resistant Tablets I.P. | Batch BLT-25798AMfg Nov 2025 · Exp Oct 2027 | Brit Lifescience V.P.O. MoginandHimachal Pradesh | MISBRANDED In the composition the label should be mentioned as Rabeprazoe sodium IP. But the label is mentioned as Rabeprazole Sodium equivalent to Rabeprazole. Hence it is misbranded drug as per section 17 of Drugs and Cosmetics Act 1940.Misbranded | DCL, TelanganaState lab |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules | Batch CG24-0548MMfg Oct 2024 · Exp Sep 2026 | Humankind Pharmaceuticals Lunia MohallaUttarakhand | Content of Rabeprazole SodiumOther | GORAKHPUR LAB, UPState lab |
| Rabepra zole Gastro Resistant Tablets IP 20 mg | Batch T-2611, 36Mfg Nov 2025 · Exp Oct 2027 | Merril Pharma Pvt. LtdUttarakhand | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| R-Zara DSR Capsules | Batch SC-08656Mfg Jan 2026 · Exp Dec 2027 | Samay Pharma India Pvt. LtdHimachal Pradesh | The sample does not pass the following test Assay Rabeprazole Sodium per capsule is 0.0 mg against claim of 20mg and Domperidone per capsule is 0.0mg against claim of 30mg.Assay | Gov Analyst Analyst. Haryana ChandigarhState lab |
| Promethazine Injection I.P. 2ml | Batch HLI992MMfg Dec 2026 · Exp Nov 2027 | Himalaya Meditek Pvt. LtdUttarakhand | The sample does not conform to I.P with respect to test for 'Particulate matter' and is also not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Pregabalin IP 75mg, Nortripyline 10mg and Methylcobalamin IP 1500mcg, | Batch ADT252729AMfg Oct 2025 · Exp Sep 2027 | Astonea Labs Pvt. LtdHaryana | The content of Methylcobalamin found to be 668.61 mcg per tablet (44.574%) against labelled claim of 1500 mcg per tablet.Labelling | Govt Analyst PunjabState lab |
| Pregabalin Capsules IP 300mg | Batch DMC-260508AMfg May 2026 · Exp Apr 2028 | Divine Medicare | The Contents of Pregabali found to be 211.16mg/Capsule against the claim of 300.0mg/Capsule.Other | Govt Analyst PunjabState lab |
| Phenytoi Tablets IP 100mg | Batch T-4710Mfg Mar 2025 · Exp Feb 2027 | Jackson Laboratories Pvt. LtdPunjab | The sample has been declared as NSQ quality with respect to Description.Description | RDTL. Bellary KarnatakaState lab |
| Pepsin & Fungal Diastase Syrup 200ml | Batch MLS25934Mfg Dec 2025 · Exp Nov 2027 | Mancare Laboratories Pvt. LtdUttarakhand | The content of fungal diastase in the sample is less(i.e.17.36% of the labelled amount) than the permissible limits.Labelling | FDAL, MumbaiState lab |
| Paracetamol, Phenylephrine HCL, Guaiphenesin, Cetirizine Hydrochloride & Ambroxol HCL Tablets | Batch SBT-3351Mfg Jul 2025 · Exp Jun 2027 | Supercure Biotech Pvt. LtdHaryana | The sample is found to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Paracetamol Tablets IP 650mg. | Batch AGT40557Mfg May 2024 · Exp Apr 2027 | Alventa Pharma LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | CDL,KolkataState lab |
| Paracetamol Tablets IP 650mg | Batch FT5427Mfg Oct 2025 · Exp Sep 2027 | Forgo PharmaceuticalsHimachal Pradesh | The sample does not conforms to the I.P. with respect to Dissolution Test.Dissolution | DTL BikanerState lab |
| Paracetamol Tablets IP 650mg | Batch T60095Mfg Mar 2026 · Exp Feb 2028 | Zenith Drugs Ltd. 72/5 & 72/3Madhya Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL,GuwahatiState lab |
| Paracetamol Tablets IP 650 mg | Batch UT-3765Mfg Jan 2024 · Exp Dec 2026 | Yacca Pharmaceutical Pvt. Ltd. 11 th KmUttarakhand | Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| Paracetamol Tablets IP 500mg | Batch CHT-50351Mfg Feb 2025 · Exp Jan 2028 | Cotec Healthcare Pvt. LtdUttarakhand | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Paracetamol.Dissolution | RDTL, GuwahatiCDSCO lab |
| Paracetamol Tablets IP 500 mg | Batch PAK-825Mfg Jan 2025 · Exp Dec 2027 | Healer's Lab Unit IIHimachal Pradesh | The sample does not conform to the IP standards with respect to the test for DissolutionDissolution | DTL, ThrissurState lab |
| Paracetamol Paediatric Syrup IP 60 ml | Batch PCS25194Mfg Sep 2025 · Exp Aug 2027 | Vivek Pharmachem (India) LtdRajasthan | The sample does not conform to IP standards. It fails the test Microbial Examination of Non- Sterile Product as per IP, as specified in the Laboratory protocol.Microbial limits | DTL, TVPMState lab |
| Paracet amol Tablets IP 650 mg | Batch YT-250671EMfg Oct 2025 · Exp Sep 2027 | Yuventis Life SciencesHimachal Pradesh | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Paracet amol Tablets IP 500 mg | Batch CTF2 5007Mfg Sep 2025 · Exp Aug 2028 | Curetech Formulations Pvt. LtdHimachal Pradesh | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Pantoprazole and Domperidone Tablets | Batch T-241215Mfg Dec 2024 · Exp Nov 2026 | Medirose Drugs & Pharmaceuticals | The sample does not conform to claim with respect to above tests and The sample is not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Pantoprazole and Domperidone Tablets | Batch AN-06-25Mfg Oct 2025 · Exp Sep 2027 | Anchor Pharma Pvt. LtdDaman & Diu | TEST FOR DISINTEGRATION TIMEDisintegration | DTL, DelhiState lab |
| Pantoprazole Tablets IP | Batch PEP5001Mfg Feb 2025 · Exp Jan 2027 | Finecure Pharmaceuticals Ltd. PF-5 & 6Gujarat | Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| Pantoprazole Tablets IP | Batch AGW01AKAMfg Sep 2025 · Exp Aug 2027 | Pure & Cure Healthcare Pvt. LtdUttarakhand | The sample does not conform to IP standards. It fails the test Dissolution.Dissolution | DTL, KonniState lab |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | Batch SPK251470Mfg Oct 2025 · Exp Mar 2028 | Aristo Pharmaceuticals Pvt. LtdSikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | Batch 25444650Mfg Dec 2025 · Exp May 2028 | Alkem Health ScienceSikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Pantoprazole Gastro-resistant Tablets IP | Batch AT-1952AMfg Jun 2025 · Exp May 2027 | Azot Life SciencesHimachal Pradesh | Content of Pantoprazole (84.7%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Pantoprazole Gastro-resistant and Domperidone Prolonged- released Capsules IP | Batch 25441645Mfg May 2025 · Exp Apr 2027 | Alkem Health ScienceSikkim | TESTS FOR ASSAY (CONTENT) OF PANTOPRAZOLE & UNIFORMITY OF WEIGHTAssay | DTL, DelhiState lab |
| Pantoprazole Gastro-resistant Tablets IP | Batch GD25214Mfg Dec 2025 · Exp Nov 2027 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | TEST FOR DISSOLUTIONDissolution | DTL, DelhiState lab |
| Pantoprazole Gastro-Resistant Tablets IP | Batch R2516403JMfg Oct 2025 · Exp Sep 2027 | Reltsen Healthcare SplPuducherry | Sample Does not meets the Specifications wrt, Dissolution (All 6 Tablets dissolved in acid stage) as per IPDissolution | DCL, TelanganaState lab |
| Pantoprazole Gastro- Resistant & Domperidone Prologed Release Capsules I.P. | Batch CG26-0049RMfg Mar 2026 · Exp Feb 2028 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | 01. ASSAY OF PANTOPRAZOLE SODIUM I.P. & DOMPERIDONE I.P. ? Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Pantopr azole Gastro Resistant Tablets IP20 mg | Batch CIT-8736Mfg Dec 2025 · Exp Nov 2027 | Conscaff IndiaHimachal Pradesh | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Pacimol MF 250 Suspension | Batch INCO14030RMfg Sep 2024 · Exp Aug 2027 | Ipca Laboratory Ltd. Sejavta | Suspension does not dispose uniformaly on shakingOther | DTL Jabalpur (M.P.)State lab |
| Pacimol MF 250 Suspension | Batch INCO14035RMfg Oct 2024 · Exp Sep 2027 | Ipca Laboratory Ltd. Sejavta | Suspension does not dispose uniformaly on shakingOther | DTL Jabalpur (M.P.)State lab |
| PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SYRUP IP | Batch XL260053Mfg Jan 2026 · Exp Dec 2027 | Xcell LabsHimachal Pradesh | pHpH | Govt Analyst PunjabState lab |
| Oxytocin Injection IP 5IU/ml, | Batch I-7881Mfg Nov 2025 · Exp Oct 2027 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample failed in Identification test of OxytocinIdentification | DTL, DelhiState lab |
| Oxytocin Injection IP 5IU/ml | Batch I-7881Mfg Nov 2025 · Exp Oct 2027 | Jackson Laboratories Pvt. LtdPunjab | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Particulate MatterIdentification | RDTL, ChandigarhCDSCO lab |
| Orlistat Capsules USP 120 mg | Batch TPC25015Mfg Sep 2025 · Exp Aug 2027 | Taj Pharma India LtdGujarat | 01.IDENTIFICATION TEST OF ORLISTAT U.S.P. ? Found to be negative. 02. ASSAY OF ORLISTAT U.S.P.: NIL.Assay | SFDTL UttarakhandState lab |
| Oral Rehydration salts IP(ORS) | Batch CHPLO- 002Mfg Feb 2026 · Exp Jan 2028 | Cureza Healthcare Pvt. Ltd. 63/1Madhya Pradesh | The sample does not conform to claim as per IP in respect to test for DescriptionDescription | SDTL, JharkhandState lab |
| Oral Rehydration Salts IP | Batch 4063Mfg May 2026 · Exp Apr 2028 | Super Formulations Pvt. Ltd | Net WeightWeight | Govt Analyst PunjabState lab |
| Oral Rehydration Salts IP | Batch 4057Mfg May 2026 · Exp Apr 2028 | Super Formulations Pvt. Ltd | Net WeightWeight | Govt Analyst PunjabState lab |
| Oral Rehydration Salts I.P | Batch ODSC-1010Mfg Nov 2025 · Exp Oct 2027 | Nestor Pharmaceuticals LimitedHaryana | Sample does not conform to IP standards. It fails the test Assay as per IP and hence declared as Not of Standard QualityAssay | RDTL ErnakulamState lab |
| Ondansetron Tablets IP 4 mg | Batch TB251158Mfg Jan 2026 · Exp Dec 2027 | Agron Remedies Pvt. Ltd | The sample received does not conform to i.p. 2022, ip addendum 2024 specification with respect to the test for related substances (total impurities) only.Related substances | CDTL, HyderabadCDSCO lab |
| Ondansetron Tablets IP 4 mg | Batch TG252335Mfg Nov 2025 · Exp Oct 2027 | Symbiosis Pharmaceuticals Pvt. Ltd. - (Plant-I) Symbiosis HouseHimachal Pradesh | Assay & DissolutionAssay | Lucknow LabState lab |
| Ondansetron Orally Disntagrating Tablets IP | Batch SPT252281Mfg Oct 2025 · Exp Sep 2027 | Salus PharmaceuticalsHimachal Pradesh | The sample has been declared as NSQ as it does not conform to IP standard with respect to Test for DisintegrationDisintegration | RDTL. Bellary KarnatakaState lab |
| Ondansetron Orally Disintegration Tablets IP | Batch ST-34645Mfg Oct 2024 · Exp Sep 2026 | Samay Pharma India Pvt. LtdHimachal Pradesh | Disintegration TestDisintegration | Lucknow LabState lab |
| Omerprazole Capsules I.P 20 mg. | Batch OPZDC4059Mfg Nov 2024 · Exp Oct 2026 | Laborate Pharmaceutical India Ltd. 111 | Test for Dissolution for Omeprazole both at Acid and Buffer StageDissolution | RDTL, Bellary KarnatakaState lab |
| Omeprazole Gastro-resistant Capsules IP 20 mg | Batch GC108503Mfg Mar 2025 · Exp Feb 2027 | Bengal Chemicals & Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to IP standards with respect to the test for Dissolution.Dissolution | DTL, ThrissurState lab |
| Omeprazole & Domperidone Capsules | Batch AC25/211Mfg Jan 2026 · Exp Dec 2027 | Accuwell Medics Private Ltd. Suvery No.-414Gujarat | Content of Omeprazole & DomperidoneOther | Lucknow LabState lab |
| Ofloxacin Metronidazole and Simethicone Suspension | Batch OXG2501Mfg Sep 2025 · Exp Aug 2027 | Apple Formulations Pvt. LtdUttarakhand | Content of Metronidazole (45.68%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Obelow-60 (Orlistat Capsules USP 60 mg | Batch TPC26003Mfg Jan 2026 · Exp Dec 2027 | Taj Pharma India LtdGujarat | 01. IDENTIFICATION TEST OF ORLISTAT U.S.P. ? Found to be negative. 02. ASSAY OF ORLISTAT U.S.P.: NIL.Assay | SFDTL UttarakhandState lab |
| ONEM Injection | Batch 70425008EMfg Nov 2025 · Exp Oct 2027 | Onxy Biotec Ltd. Unit-IIHimachal Pradesh | pHpH | ChandigarhState lab |
| Nimesulide & Paracetamol Tablets | Batch Not MentionedMfg ? · Exp ? | Euphoria India PharmaceuticalsHimachal Pradesh | MISBRANDED DRUGS.Misbranded | SFDTL UttarakhandState lab |
| Nifedipine Sustained Release Tablets IP 10mg | Batch ANY25001Mfg Dec 2025 · Exp Nov 2028 | J.B. Chemicals & Pharmaceuticals LtdGujarat | The sample does not conforms to the claim with respect to Dissolution (Acid Stage).Dissolution | DTL JaipurState lab |
| Nicoz-5 Nicorandil Tablets IP 5 mg | Batch NBT-251045Mfg Oct 2025 · Exp Sep 2027 | A.N.D Healthcare LtdPunjab | Sample does not conform to IP Standards. If fails the test 'Dissolution' and 'Assay'Assay | RDTL ErnakulamState lab |
| Milk of Magnesia, Liquid Paraffin & Sodium Picosulfate Suspension | Batch UF2834807BMfg Oct 2024 · Exp Sep 2026 | Ultra Durgs Formulations Pvt. LtdHimachal Pradesh | Description onlyDescription | RDTL. Bellary KarnatakaState lab |
| Midazolam injection I.P-1mg-5ml | Batch MZ-2606Mfg Jan 2026 · Exp Dec 2027 | Vindas Chemical Industries (P) Ltd | pH (4.1) and Assay (87.2%)Assay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Metronidazole and Povidone Iodine Ointment | Batch XOJM25015Mfg Jul 2025 · Exp Jun 2027 | Helios Pharmaceuticals (Div. of P.K.T.P. Pvt LtdHimachal Pradesh | The sample does not conform to Label claim with respect to the content of Availabe Iodine in Povidone Iodine(79.59%)Labelling | Drugs Testing Laboratory, Madurai-19State lab |
| Metronidazole Tablets IP 400 mg | Batch T4500Mfg Nov 2024 · Exp Apr 2027 | Titanes Pharma | The sample does not conforms to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab |
| Metronidazole Tablets IP 200 mg | Batch MZ241001Mfg Oct 2024 · Exp Sep 2026 | Cipco Pharmaceuticals 35-36/1Madhya Pradesh | The Dissolution test Does Not Complies as per IP Specification, hence it is of Not of Standard Quality.Dissolution | DCL, TelanganaState lab |
| Metronidazole Tablets IP 200 mg | Batch ME025002Mfg Dec 2025 · Exp Nov 2028 | Danish Healthcare (P) Ltd. 76/27-29 | Uniformity of WeightUniformity of weight/content | Lucknow LabState lab |
| Metronidazole Infusion B.P. 0.5% w/v | Batch L04A032607Mfg Mar 2026 · Exp Feb 2029 | Althea Pharma Pvt. LtdDaman & Diu | The sample does not comply as per B.P. 2025 with respect to the test for Sterility.Sterility | RDTL, GuwahatiCDSCO lab |
| Methylprednisolone Tablets I.P. | Batch NHD24554AMfg Nov 2024 · Exp Oct 2026 | Nest Healthcare Pvt.LtdGujarat | The sample does not conform to IP with respect to the test for DissolutionDissolution | CDTL, IndoreCDSCO lab |
| Methylcobalamin Alpha Lipoic Acid Pyridoxine HCL Folic Acid &Vitamin D3 Tablets | Batch LC25F031CMfg Jun 2025 · Exp Nov 2026 | Life care Neuro Products Ltd. 70/1Himachal Pradesh | Disintegration testDisintegration | RDTL, Bellary KarnatakaState lab |
| Metformin Hydrochloride Prolonged-Released and Glimepiride Tablets IP | Batch 60002727Mfg Mar 2026 · Exp Feb 2028 | USV Private LimitedGujarat | The sample does not conform to claim as per Manufacture's Specification with respect to the test for Dissolution of Metformin Hydrochloride.Dissolution | CDTL, IndoreCDSCO lab |
| Mefenamic Acid & Paracetamol Tablets | Batch T-252174Mfg Mar 2025 · Exp Feb 2027 | Merril Pharma Pvt. LtdUttarakhand | The sample does not conform to Schedule V of the Drugs Rule 1945 with respect to the test disintegration.Disintegration | DTL, ThrissurState lab |
| METHOTREXATE TABLETS IP 7.5 MG | Batch L09-2501Mfg Feb 2025 · Exp Jan 2027 | Macmillon Pharmaceuticals Pvt LtdPunjab | DescriptionDescription | Govt Analyst PunjabState lab |
| METHOTREXATE TABLETS IP 7.5 MG | Batch L09-2402Mfg Dec 2024 · Exp Nov 2026 | Macmillon Pharmaceuticals Pvt LtdPunjab | DescriptionDescription | Govt Analyst PunjabState lab |
| Levofloxacin Tablets IP 500 mg | Batch JC00116Mfg Jan 2026 · Exp Dec 2027 | Lupin Ltd. EPIPJammu & Kashmir | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Levodropropizine & Chlorpheniramine Maleate Syrup | Batch FL5024Mfg Jun 2025 · Exp May 2027 | Forgo PharmaceuticalsHimachal Pradesh | The sample does not conform to Manufacturer's specification with respect to test for'pH and Assay of Chlorpheniramine Maleate.Assay | CDL, KolkataCDSCO lab |
| Levocetirizine Dihydrochloride Tablets I.P. | Batch B13225006Mfg Nov 2025 · Exp Oct 2027 | Torque Pharmaceuticals Pvt. Ltd | The sample does not conform to the I.P. with respect to Dissolution of Levocetirizine Dihydrochloride.Dissolution | DTL JodhpurState lab |
| Levocetirizine & Montelukast Sodium Dispersible tablets | Batch ABC04ABAMfg Dec 2025 · Exp Nov 2027 | Pure & Cure Healthcare Pvt. LtdUttarakhand | The sample does not conform to Label claim with respect to content of Montelukast in Montelukast sodium)Labelling | Drugs Testing Laboratory, Madurai-19State lab |
| Lactic Acid Bacillus Capsules | Batch DY0225060Mfg Nov 2025 · Exp Oct 2027 | Uni MedicolabsUttarakhand | The sample does not conform to Manufacturer's specification with respect to test for Microbial Limit Test with regard to Total Yeast and Mold countMicrobial limits | CDL, KolkataCDSCO lab |
| KUFFTUSS-Q Tablets | Batch IGT-0511Mfg Dec 2024 · Exp Nov 2027 | IG Pharma Ltd. 12.4 KM Meerut Road Roorkee Dist. Haridwar (U.K.)Uttarakhand | Mottled appeareanceOther | DTL Jabalpur (M.P.)State lab |
| KT Kids Cleansing Shampoo Soothes the scalp 200 ML | Batch KTK0012Mfg Apr 2026 · Exp Apr 2028 | CCIGMAA LIFESTYLE Pvt LTD. 12 ACO-OP 2 nd FloorMaharashtra | The Sample Does Not Comply With Is 17117:2019 (Reaffirmed 2024) For Hair Shampoo For Babies Specification Req(Jirements For Micribial Count. The Sample Is Misbranded for the Manner of Labelling As Given Rule 34(10) (e) and rule 35 of cosmetics rule 2020.Misbranded | FDAL, MumbaiState lab |
| Itraconazole, Capsules IP | Batch CG25-0392AMfg Nov 2025 · Exp Oct 2027 | Athens Life Sciences Mauza-Rampur Jatten Nahan RoadHimachal Pradesh | AssayAssay | Lucknow LabState lab |
| Itraconazole 100mg IP | Batch MC004Mfg Jul 2025 · Exp Jun 2027 | MK Healthcare | 1. The content of Itraconazole found to be 63.54 mg per capsule (63.54%) against labelled claim of 100 mg per capsule. 2. The composition on the label is not as per I.P monographLabelling | Govt Analyst PunjabState lab |
| Iron, Folic Acid, Cyanocobalamin & Zinc Sulphate Syrup | Batch BV616Mfg Oct 2025 · Exp Mar 2027 | Biva Healthcare | The sample does not conform to claim as per Schedule V of Drugs and Cosmetics Rules 1945 with respect to Assay of Cyanocobalamin.Assay | CDL, KolkataCDSCO lab |
| Iron n& Folic Acid Tablets I? | Batch QT1572Mfg Mar 2025 · Exp Feb 2027 | Quest Laboratories Pvt. LtdMadhya Pradesh | The sample does not conform to claim as per IP in respect to test for DescriptionDescription | SDTL, JharkhandState lab |
| Ibuprofen Tablets I.P. 400 mg | Batch IBPT-1003Mfg Jul 2024 · Exp Jun 2027 | Wings Biotech LLPHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Ibuprofen.Dissolution | RDTL, GuwahatiCDSCO lab |
| Ibuprofen Tablets IP 200 mg | Batch INR25036Mfg Nov 2025 · Exp Oct 2027 | Danish Healthcare (P) Ltd. 76/27-29 | DissolutionDissolution | Lucknow LabState lab |
| Handloom Rolled Bandages | Batch 024Mfg Jan 2026 · Exp Dec 2027 | Kota Saree Avam Hath kargha Vastra Utpadak Kray-Vikray Sahakari Samiti Ltd | The sample does not conform to claim as per Schedule F-(II) with respect to test for FluorescenceOther | CDL, KolkataCDSCO lab |
| Hajmola Regular | Batch BM1250Mfg Mar 2026 · Exp Feb 2028 | Dabur India LtdHimachal Pradesh | Total 120 Tablets received for analysis,out of 120 Tablets, 13 Tablets are found in broken condition and some powder is found in container when observed in normal day light with unaided eyes.Other | FDAL, Chhatrapati SambhajinagarState lab |
| Glipizide Tablets IP | Batch SPA252473Mfg Nov 2025 · Exp Oct 2027 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab |
| Glimepiride, Ploglitazonehci & Metformin HCI (SR) Tablets | Batch DPT-016Mfg Apr 2025 · Exp Mar 2027 | Demexico Pharmaceuticals Pvt. LtdUttarakhand | The sample has been declared as NSQ as it does not conform to label claim with respect to Assay for Metformin Hydrochloride and PioglitazoneAssay | RDTL. Bellary KarnatakaState lab |
| Glimepiride Tablets IP 4mg | Batch T2512152Mfg Dec 2025 · Exp Nov 2027 | Rivpra Formulation Pvt. LtdUttarakhand | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab |
| Glimepiride Tablets IP 2mg | Batch CHPLT1027Mfg Dec 2025 · Exp Nov 2027 | Cureza Healthcare Pvt. LtdMadhya Pradesh | The Sample does not Comply with IP Requirements for the Dissolution Test.Dissolution | FDAL, Chhatrapati SambhajinagarState lab |
| Glimepiride Tablets IP 1mg | Batch GTA-2501Mfg Jan 2025 · Exp Jan 2027 | Apple Formulations Pvt. LtdUttarakhand | The sample does not conform to standard quality in respect of the test for ?Description? performed.Description | SDTL, Tripura, AgartalaState lab |
| Glimepiride Tablets IP | Batch 5GAC030Mfg Dec 2025 · Exp Nov 2028 | Sanofi India LimitedGoa | DissolutionDissolution | Lucknow LabState lab |
| Gliclazide Extended release Tablets 60 mg | Batch T511617Mfg Nov 2025 · Exp Oct 2027 | ION Healthcare Pvt. Ltd.Baddi- Barotiwala Road Baddi Distt. Solan (H.P) 173205Himachal Pradesh | test for Dissolution for Gliclazide at 4th hour and 12th hour as per Manufacturer's methodDissolution | RDTL. Bellary KarnatakaState lab |
| Folic Acid Tablets IP | Batch F0L1T5010Mfg Oct 2025 · Exp Sep 2027 | Acme Life Tech-LLPHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Folic Acid.Dissolution | RDTL, GuwahatiCDSCO lab |
| Folic Acid Tablets IP | Batch SPT-41378Mfg Nov 2025 · Exp Oct 2027 | Shervotec PharmaceuticalsHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Folic acid.Dissolution | RDTL, GuwahatiCDSCO lab |
| Flexon Suspension | Batch DPK241894Mfg Oct 2024 · Exp Sep 2027 | Aristo Pharmaceuticals Pvt. LtdDaman & Diu | Suspension does not dispose uniformaly on shakingOther | DTL Jabalpur (M.P.)State lab |
| Ferrous Ascorbate, Folic Acid and Cyanocobalamin Suspension | Batch 18260226AMfg Jan 2026 · Exp Dec 2028 | Macleods Pharmaceuticals LtdSikkim | Identity test negative for Folic Acid & content of Elemental IronOther | Lucknow LabState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch LTA-45315AMfg Oct 2024 · Exp Sep 2026 | Life Vision HealthcareHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-677Mfg Aug 2025 · Exp Jan 2027 | Healer's Lab Unit IIHimachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-656Mfg Aug 2025 · Exp Jan 2027 | Healer's Lab Unit IIHimachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-629Mfg May 2025 · Exp Oct 2026 | Healer's Lab Unit IIHimachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-649Mfg May 2025 · Exp Oct 2026 | Healer's Lab Unit IIHimachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-628Mfg May 2025 · Exp Oct 2026 | Healer's Lab Unit IIHimachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Assorbate, Folic Acid and Cyanocobalamin Suspension | Batch 18260226AMfg Jan 2026 · Exp Dec 2028 | Macleods Pharmaceuticals LtdSikkim | 01. ASSAY OF FOLIC ACID I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Ferric Carboxymaltose Injection 50 mg/ml | Batch RC26003Mfg Jan 2026 · Exp Dec 2027 | Maan Pharmaceuticals LtdGujarat | The sample does not conform to Manufacturer's specification with respect to test for Particulate matter and Bacterial endotoxins.Particulate matter | CDL, KolkataCDSCO lab |
| FORMALDEHYDE SOLUTION B.P. | Batch F-25Mfg Dec 2025 · Exp Nov 2027 | Vinayak Manutrade (P) LtdRajasthan | The sample does not conforms to the BP with respect to Description.Description | DTL JaipurState lab |
| Dynaflex Plus | Batch VGT240120Mfg Jun 2024 · Exp May 2027 | Vapi Care Pharma Pvt. Ltd | NSQOther | DTL BhopalState lab |
| Drotaverine Hydrochloride & Diclofenac Potassium Tablets | Batch KFCR6023Mfg Mar 2026 · Exp Feb 2028 | Cris Pharma (India) Ltd. E-11Uttarakhand | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Dr. Wash Intimate Hygiene | Batch IW-0225Mfg Feb 2025 · Exp Jan 2028 | Magic of Herbs Magic of Herbs Haryana-133001Haryana | Idetity test Negative for Lactic AcidOther | VARANASI,UPState lab |
| Disposable Syringe for Single Use Only (STERILIFE) 2ml | Batch 052502GX01Mfg May 2025 · Exp Apr 2028 | Sterisafe Health Solutions | The sample does not comply as per IP 2022 with respect to the test for Sterility.Sterility | RDTL GuwahatiState lab |
| Dinoprostone Gel | Batch H-084Mfg Feb 2025 · Exp Jan 2027 | Cotec Healthcare Pvt. LtdUttarakhand | The sample does not conforms to the claim with respect to Average fill, Uniformity of weight and Assay.Assay | DTL JaipurState lab |
| Dinoprost Tromethamine Injection | Batch VPT409Mfg Sep 2025 · Exp Aug 2027 | Vetsun PharmaceuticalsUttarakhand | pHpH | Govt Analyst PunjabState lab |
| Diclofenac Sodium and Paracetamol Tablets IP | Batch I501103Mfg Feb 2025 · Exp Jan 2027 | Zydus Healthcare LtdSikkim | Description & DissolutionDissolution | Lucknow LabState lab |
| Diclofenac Sodium Tablets IP 50mg | Batch SP250935Mfg Sep 2025 · Exp Aug 2027 | Sharun Pharmaceuticals Pvt.LtdPuducherry | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Diclofenac Sodium Tablets IP 50mg | Batch SP250934Mfg Sep 2025 · Exp Aug 2027 | Sharun Pharmaceuticals Pvt.LtdPuducherry | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Diclofenac Sodium Tablets IP 50 mg | Batch DG 5033Mfg Mar 2025 · Exp Feb 2027 | Kerala State Drugs Pharmaceuticals LtdKerala | The sample does not conform to IP standards with respect to the test Dissolution and also shows Category B defect of tablets (Capping).Dissolution | DTL, ThrissurState lab |
| Diclofenac Sodium Injection I.P. | Batch ZYCD15018Mfg Oct 2025 · Exp Sep 2027 | Laborate Pharmaceutical India Ltd. 111Himachal Pradesh | Content of Diclofenac SodiumOther | KANPUR LAB, UPState lab |
| Diclofenac Sodium Gastro -Resistant Tablets IP | Batch T-25056Mfg Sep 2025 · Exp Aug 2027 | Geson Pharma Pvt. Ltd Industrial AreaUttar Pradesh | Disintegration TestDisintegration | MEERUT LABState lab |
| Diclofenac Sodium & Paracetamol Tablets | Batch AHT-2502262Mfg Feb 2026 · Exp Jan 2028 | Aru Health Care Pvt. Ltd. - K-12 | Disintegration TestDisintegration | Lucknow LabState lab |
| Diclofenac Gastro-Resistant Tablets IP | Batch 250264AMfg May 2025 · Exp Apr 2028 | Bal Pharma LimitedUttarakhand | The sample does not conform to I.P 2022 with respect to test for Related substancesRelated substances | CDTL, MumbaiCDSCO lab |
| Diclofenac Diethylamine, Virgin Linseed oil, Menthol & Methyl Salicylate Gel | Batch JDB766Mfg Feb 2025 · Exp Jan 2027 | Curetech SlincareHimachal Pradesh | The sample does not conform to label claim with respect to the content of Diclofenac Diethylamine,and Methyl SalicylateLabelling | Drugs Testing Laboratory, Chennai-06State lab |
| Diabetis-All Powder | Batch A-1Mfg Jul 2025 · Exp Jul 2030 | Dr. Puri Proprietory Product | The Sample gives TLC and HPLC [dentification Test for the Presence of Pioglitazone Hydrochloride. lFound Content of Pioglitazone Hydrochloride: 0.32mg/gm. The Sample is declared as Spurious Vide Section 33-EEA(d) of Drugs And Cosmetics Act 1940 and Rules thereunder.Spurious | FDAL, Chhatrapati SambhajinagarState lab |
| Dextromethorphan HBr, Phenylephrine HCl & Chlorpheniramine Maleate Syrup). | Batch ABSL25-0183AMfg Oct 2025 · Exp Sep 2027 | Alexin BiosciencesHimachal Pradesh | MISBRANDED DRUGS.Misbranded | SFDTL UttarakhandState lab |
| Dexamethasone Tablets IP 0.5 mg | Batch KJKBH25134Mfg Nov 2025 · Exp Oct 2028 | Cadila Pharmaceuticals Ltd. Industrial Growth Center | DissolutionDissolution | Lucknow LabState lab |
| Deomax-LB (Amoxycillin. Cloxaeillin & Lactic Acid Closacillin & Lacne Acd Bacillus Capsules | Batch JPC-3100Mfg Oct 2024 · Exp Sep 2026 | JMH PharmaUttarakhand | The sample does not pass the Assay of Anhy drous Amoxycillin & Cloxacillin per capsule is 10.86 mg & 67.73 mg against the claimed 250 mg.Assay | Gov Analyst Analyst. Haryana ChandigarhState lab |
| Cypermethion 10% High Cis | Batch 9023Mfg Aug 2025 · Exp Jul 2027 | Mac Royal Biotech Baddi RoadHimachal Pradesh | Assay for Cypermethrin highcisAssay | RDTL. Bellary KarnatakaState lab |
| Culse The Beauty soap papaya Fruit Mix | Batch CT06Mfg Jan 2025 · Exp May 2027 | Goodbuy Beauty Prohtets Door no. 13/515 A | Test for Matter Insolubic in AlcoholOther | RDTL. Bellary KarnatakaState lab |
| Compound Sodium Lactate Injection IP | Batch EE26A003Mfg Jan 2026 · Exp Dec 2027 | Hindustan PolyfabHimachal Pradesh | The sample does not conform to I.P. with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Compound Sodium Lactate Injection I.P. | Batch EE26A006Mfg Jan 2026 · Exp Dec 2027 | Hindustan PolyfabHimachal Pradesh | The sample does not conform to I.P. with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Colecalciferol Drops | Batch 26-XJFD-098Mfg Apr 2026 · Exp Sep 2027 | Stedman Pharmceuticals Pvt.Ltd | The sample does not conform to claim with respect to the test for Related substances.Related substances | CDL, KolkataCDSCO lab |
| Clopidogrel & Aspirin Tablets IP | Batch P0825176TMfg Aug 2025 · Exp Jul 2027 | Pharmaroots HealthcareHimachal Pradesh | Dissolution, Free Salicylic Acid, Content of Clopidogrel (38.20%) and Aspirin (21.8%)Dissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Clopidogrel & Aspirin Tablets | Batch TSF-C2763Mfg Oct 2024 · Exp Sep 2026 | Spen Formulations Pvt. Ltd | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab |
| Clopidogrel & Aspirin Tablets | Batch GT31923CMfg Feb 2026 · Exp Jan 2028 | J.M. LaboratoriesHimachal Pradesh | Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Clobetasol Propionate, Neomycin, Miconazole Nitrate & Chlorhexidine Cream | Batch DLPS5111Mfg Nov 2025 · Exp Oct 2027 | Leeford Healthcare LtdHimachal Pradesh | Content of Chlorhexidine (51.5%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Ciprofloxacin Hydrochloride Tablets IP 250mg | Batch T50540Mfg Dec 2025 · Exp Nov 2027 | Zenith Drugs Pvt. LtdMadhya Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL,GuwahatiState lab |
| Cinnarizine Tablets IP | Batch MV115027Mfg Dec 2025 · Exp Nov 2028 | Geno Pharmaceuticals Pvt. LtdGoa | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Chlorhexidine Mouthwash IP | Batch WOR25041GMfg Dec 2025 · Exp Nov 2028 | Windlas Biotech Limited (Plant-2)Uttarakhand | The sample does not conform to claim as per I.P. 2022 with respect of test for Assay of Chlorhexidine Gluconate.Assay | RDTL, GuwahatiCDSCO lab |
| Cetin Plus Suspension 60ml | Batch GL027412Mfg Dec 2024 · Exp Nov 2026 | Asian PharmaHimachal Pradesh | NSQOther | DTL BhopalState lab |
| Celltus-B (Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup) | Batch CLAM-2525Mfg Dec 2025 · Exp Nov 2027 | Comex Pharma | 01. ASSAY OF TERBUTALINE SULPHATE I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Cefuroxime Axetil & Potassium Clavulanate Tablets I.P. | Batch CXCA25014EMfg Aug 2025 · Exp Jan 2027 | J.M. LaboratoriesHimachal Pradesh | The sample does not conform to I.P. with respect to the tests of Dissolution and Assay of Cefuroxime and Clavulanic Acid.Assay | CDL, KolkataCDSCO lab |
| Cefpodoxime Proxetil Oral Suspension IP | Batch LBL2501002Mfg Jan 2026 · Exp Dec 2027 | Life Gem Medi Healthcare (India) I.P. - 46 Raipur Sahkari Audhyogic KshetraUttarakhand | AssayAssay | Lucknow LabState lab |
| Cefpodoxime Proxetil IP 200 mg Tablets | Batch SRTC-2403Mfg Aug 2025 · Exp Jul 2027 | Velnex Medicare India Pvt. Ltd | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Cefpodoxime Proxetil & Clavulanic Acid Tablets | Batch BT-0564Mfg Sep 2025 · Exp Feb 2027 | Addll Biotech Pvt. LtdHimachal Pradesh | Identity test negative for Cefpodoxime Proxetil & Clavulanic AcidOther | Lucknow LabState lab |
| Cefpodoxime Dispersible Tablets Nexopod -100DT | Batch BL-033E25Mfg May 2025 · Exp Apr 2027 | Austin Pharmaceuticals Ltd. E-40Punjab | The sample fails in the test, DescriptionDescription | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Cefpodoxime & Ofloxacin Tablets | Batch C9AKX031Mfg Dec 2024 · Exp Nov 2026 | Relax Pharmaceuticals Pvt. Ltd. - (Unit-II) 49-A-BHimachal Pradesh | Identity test negative for Cefpodoxime Proxetil & OfloxacinOther | Lucknow LabState lab |
| Cefixime, Ofloxacine & Lactic Acid Bacillus Tablets | Batch ST-25190Mfg Jan 2026 · Exp Dec 2027 | Candimed Life SciencesUttarakhand | Identity test negative for Cefixime & OfloxacinOther | Lucknow LabState lab |
| Cefixime, Azithromycin and Lactic Acid Bacillus Tablets | Batch TB25115Mfg Mar 2025 · Exp Feb 2027 | Forgo Pharmaceuticals (P) LtdHaryana | Content of anhydrous AzithromycinOther | GORAKHPUR LAB, UPState lab |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | Batch ST-25193Mfg Jan 2025 · Exp Dec 2027 | Candimed Life SciencesUttarakhand | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | Batch PL-26089Mfg Sep 2025 · Exp Aug 2027 | Velnex Medicare India Pvt. Ltd | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab |
| Cefixime with Lactic Acid Bacillus Dispersible Tablets | Batch CT/25/792Mfg Jan 2026 · Exp Dec 2027 | Ciphem PharmaGujarat | The sample does not conform to the claim with respect to Assay of Cefixime Trihydrate Eq. to Anhydrous Cefixime.Assay | DTL JaipurState lab |
| Cefixime Tablets IP | Batch 25460922Mfg May 2025 · Exp Apr 2027 | Alkem Health Sciences A Unit of Alkem Laboratories Ltd. Unit-2Sikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Cefixime Dispersible Tablets IP 200mg | Batch 25D-BT150Mfg Jul 2025 · Exp Jun 2027 | Orison Pharma InternationalHimachal Pradesh | The Sample does not Comply for Description as the Tablets shows Light Brown coloured Spots all over the Surface of the Tablets.Description | FDAL, Chhatrapati SambhajinagarState lab |
| Cefixime Dispersible Tablets IP | Batch DB240368Mfg Dec 2024 · Exp Nov 2026 | Daxin Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab |
| Cefixime Dispersible Tablets I.P. | Batch CCT-24035Mfg Jul 2024 · Exp Jun 2026 | Catrax Healthcare Pvt. LtdHimachal Pradesh | 01. ASSAY OF CEFIXIME TRIHYDRATE I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Cefixime & Ofloxacin Dispersible Tablets | Batch T4646Mfg Nov 2024 · Exp Apr 2027 | Titanes Pharma | The sample does not conform to the claim with respect to Assay, Uniformity of dispersion and Disintegration.Assay | DTL JaipurState lab |
| Cefixime & Lactic Acid Bacillus Tablets | Batch DF-8021Mfg Mar 2026 · Exp Feb 2028 | Velnex Medicare India Pvt. Ltd | Identity test negative for CefiximeOther | Lucknow LabState lab |
| Cefixime & Azithromycin Tablets | Batch MWDC-5421GMfg Jan 2026 · Exp Dec 2027 | Geenac PharmaUttarakhand | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab |
| Carvedilol Tablets IP 6.25mg | Batch P1225138TAMfg Dec 2025 · Exp Nov 2027 | Pharma Roots HealthcareHimachal Pradesh | DissolutionDissolution | Drug testing laboratory, Chennai-6State lab |
| Calcium citarate malate, Vitamain k2 -7, Vitamin D3, methylcobalamin Zinc and Magnesium Tablets | Batch 25KHT-0857Mfg Aug 2025 · Exp Jul 2027 | Kaalimga Healthcare 1st FloorHimachal Pradesh | test for Disintegration and label claim woth respect to the Identification and Assay for Vitamin D3Assay | RDTL. Bellary KarnatakaState lab |
| Calcium and Vitamin D3 Tablets IP 500mg/250 IU | Batch PJCT-021Mfg Feb 2025 · Exp Jan 2027 | Laborate Pharmaceuticals India LtdHimachal Pradesh | Identification of Vitamin D3 - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Calcium and Vitamin D3 Tablets IP 500mg/250 I.U | Batch PJCT-016Mfg Feb 2025 · Exp Jan 2027 | Laborate Pharmaceuticals India Ltd. 31 Rajban Road nariwalaHimachal Pradesh | Assay for Vitamin D3Assay | RDTL. Bellary KarnatakaState lab |
| Calcium and Vitamin D3 Tablets IP | Batch CH26T203Mfg May 2026 · Exp Oct 2027 | Cureza Healthcare Pvt. LtdMadhya Pradesh | Dissolution:-(Calcium) Does not complies with IP limit as 3 out of 6 tablets are less than Q-25% Also some tablets can't even dissolve completely within the prescribed time limit.Dissolution | Govt Analyst PunjabState lab |
| Bupropion Hydrochloride Prolonged Release Tablets IP | Batch LGT-260293Mfg Feb 2026 · Exp Jan 2028 | Live Well HealthcareHimachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC, Identification by IR and Assay of Bupropion Hydrochloride.Assay | RDTL, ChandigarhCDSCO lab |
| Buprenorphine Injection IP. 2ml | Batch BUP324040Mfg Dec 2024 · Exp Jul 2026 | Indus Pharma Pvt. LtdRajasthan | The sample does not conform to I.P. with respect to tests of Particulate matter and Assay of Buprenorphine.Assay | CDL, KolkataCDSCO lab |
| Buprenorphine 2 mg and Naloxone 0.5 mg Sublingual Tablets IP | Batch 25CT0314Mfg Mar 2025 · Exp Feb 2027 | Consern Pharna LtdPunjab | The sample is of not of standard quality for the reason stated under DescriptionDescription | RDTL,GuwahatiState lab |
| Buprenorphine 2 mg and Naloxone 0.5 mg Sublingual Tablets I.P. | Batch 25CT0314Mfg Mar 2025 · Exp Feb 2027 | Consern Pharma LimitedPunjab | The sample is not of standard quality for the reason stated under Description of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Bithoquin Bolus | Batch V260301Mfg Mar 2026 · Exp Jun 2027 | Apple Biotech Healthcare Pvt. LtdPunjab | Disintegration TestDisintegration | AGRA,State lab |
| Bisacodyl Tablets IP 5mg | Batch 8676Mfg Mar 2026 · Exp Feb 2029 | Healthy Life Pharma Pvt. LtdMaharashtra | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab |
| Betamethasone, Clindamycin & Nicotinamide Cream | Batch 1391Mfg Feb 2026 · Exp Jan 2028 | Lucrose Pharma Pvt. Ltd. Flat No. 197Uttar Pradesh | Content of Betamethasone & ClindamycinOther | GORAKHPUR LAB, UPState lab |
| Betamethasone valerate & Salicylic Acid Ointment | Batch BE533Mfg Jun 2025 · Exp May 2027 | Bestcare Formulation PvtPuducherry | Content (Nil)Other | Drug testing laboratory, Chennai-6State lab |
| Betamethasone Valerate Ointment IP | Batch RF695Mfg Jun 2025 · Exp May 2027 | Curetech SkincareHimachal Pradesh | Content of Betamethasone (73.7%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Betamethasone Sodium Phosphate Injection I.P. | Batch HL11006MMfg Dec 2025 · Exp Nov 2027 | Himalaya Meditek Pvt. LtdUttarakhand | The sample does not conforms to the IP with respect to Description, Particulate Matter and Assay.Assay | DTL JaipurState lab |
| BETAMETHASONE VALERATE AND NEOMYCIN SKIN CREAM | Batch YW6KMfg Feb 2026 · Exp Jul 2027 | GlaxoSmithKline Pharmaceuticals LimitedMaharashtra | The Sample does not conform to claim with respect to the Assay of Neomycin Sulphate.Assay | DTL, DelhiState lab |
| Atorvastatin and Clopidogrel Tablets | Batch PGT25-3110AMfg Nov 2025 · Exp Oct 2027 | Plena RemediesHimachal Pradesh | Does not conform to required standards with respect to the test AssayAssay | Food & Drugs Laboratory Bambolim, GoaState lab |
| Atorvastatin Tablets IP 10mg | Batch AV26072Mfg Apr 2026 · Exp Sep 2027 | Eurokem Laboratories Pvt ltd | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Amoxyclllin CapsulesIP 250mg | Batch MBC-111Mfg Oct 2024 · Exp Sep 2026 | Mayasha Lifesciences H.B. 86Himachal Pradesh | The sample fails to comply in respect of contains of the drug which is less than the calimOther | DTL BhopalState lab |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tablets | Batch BR-1227Mfg Mar 2026 · Exp Aug 2027 | Velnex Medicare India Pvt. Ltd | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amoxycillin and Potassium Clavulanate Tablets IP (500 mg+125mg | Batch CVTC-815Mfg Sep 2025 · Exp Aug 2027 | Nestor Pharmaceuticals Limited 11Haryana | Content of Clavulanic AcidOther | GORAKHPUR LAB, UPState lab |
| Amoxycillin and Potassium Clavulanate Tablets IP | Batch CBZ19ADAMfg Dec 2025 · Exp Nov 2027 | Malik Lifesciences Pvt. LtdUttarakhand | Dissolution of AmoxycillinDissolution | Lucknow LabState lab |
| Amoxycillin Oral Suspension IP | Batch AMS2532Mfg Jun 2025 · Exp Nov 2026 | Modern LaboratoriesMadhya Pradesh | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Dispersible Tablets IP | Batch UOT25-522Mfg Sep 2025 · Exp Aug 2027 | Unisharp Organics Pvt. Ltd. Alamgir | AssayAssay | Lucknow LabState lab |
| Amoxycillin Capsules IP 500mg | Batch BC12250010Mfg May 2025 · Exp Apr 2027 | Alencure Biotech Pvt LtdHimachal Pradesh | Content of Amoxycillin (82.7%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Amoxycillin &Potassium Clavulanate Tablets | Batch Not MentionedMfg ? · Exp ? | Astam Healthcare Pvt. LtdHimachal Pradesh | MISBRANDED DRUGS.Misbranded | SFDTL UttarakhandState lab |
| Amoxycillin & Potassium Clavulanate, Lactic Acid Bacillus Tablets | Batch MWDC-5421GMfg Jan 2026 · Exp Dec 2027 | Sabi Pharmaceuticals Pvt. Ltd - . Shivnath Gogoi PathAssam | Identity test negative for Amoxycillin & Clavulanic AcidOther | Lucknow LabState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch KT25030Mfg Feb 2025 · Exp Jan 2027 | Orbit Lifescience Pvt. Ltd | The sample does not conform to I.P. w.r.to the tests for Dissolution and Assay of Clavulanic AcidAssay | CDL,KolkataState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch VT251527Mfg Sep 2025 · Exp Feb 2027 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for Dissolution and Assay of Clavulanic AcidAssay | CDL,KolkataState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch 826D074Mfg Mar 2026 · Exp Aug 2027 | Medreich LimitedKarnataka | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch MFL0122Mfg Mar 2025 · Exp Feb 2027 | Medicef PharmaHimachal Pradesh | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch TB250343CMfg Jun 2025 · Exp Feb 2027 | Polestar Power Industries (Pharma Division)Himachal Pradesh | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amoxycillin & Potassium Clavulanate Tablets I.P. | Batch HPT25002Mfg Jun 2025 · Exp Nov 2026 | Hariom PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay and Dissolution of Amoxycillin and Clavulanic Acid.Assay | RDTL, GuwahatiCDSCO lab |
| Amoxycillin & Cloxacillin Capsules | Batch ZABG2611Mfg May 2026 · Exp Oct 2027 | Malik Lifesciences Pvt. LtdUttarakhand | The sample does not conform to Manufacture's Specification with respect to the test for Assay of Amoxycillin Trihydrate eq. to Amoxycillin and Cloxacillin Sodium equivalent to Cloxacillin and Dissolution Cloxacillin Sodium equivalent to CloxacillinAssay | CDTL, IndoreCDSCO lab |
| Amoxicillin and Potassium Clavulanate Tablets IP | Batch 26440256Mfg Jan 2026 · Exp Jun 2027 | Alkem Health Sciences A Unit of Alkem Laboratories Ltd. Unit-2Sikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amino Acids (10%w/v) Injection with Electrolytes, Dextrose Injection IP (15%w/v) and Intravenous Fat Emulsion with Medium & Long Chain Triglycerides (20% w/v) in a Triple Chamber Bag | Batch 5D250116Mfg Apr 2025 · Exp Mar 2027 | Acculife Healthcare Pvt. LtdGujarat | The sample does not conform to claim with respect to Assay of L-Cysteine Hydrochloride Monohydrate, Sterility and Bacterial Endotoxin test of Infusion set.Assay | CDL, KolkataCDSCO lab |
| Amikacin Sulphate Injection IP 250mg/2ml | Batch PVI25042Mfg Dec 2025 · Exp Nov 2027 | Plica Vaccines Pvt. Ltd | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guiaphenesin & Menthol Syrup | Batch FMX-030/26Mfg Mar 2026 · Exp Feb 2028 | Finemax Formulation Pvt. LtdTamil Nadu | The sample does not conform to label claim with respect to the content of Ambroxol Hydrochloride and Terbutaline Sulphate.Labelling | Drugs Testing Laboratory, Chennai-06State lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | Batch BGL250945Mfg Sep 2025 · Exp Aug 2027 | Bestcare Formulation PvtPuducherry | Content of Ambroxol Hydrochloride(75.7%) and Terbutaline Sulphate (85.6%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Alprazolam Tablets IP 0.5mg | Batch TA25315Mfg Mar 2025 · Exp Feb 2028 | Saintlife Pharmaceuticals LtdUttarakhand | The sample does not conform to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab |
| Alprazolam Tablets IP 0.50 mg | Batch AT25417Mfg Oct 2025 · Exp Sep 2028 | Aarpik Pharmaceuticals Pvt. Ltd. C1/306/5Kerala | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Alfacalcidol with Calcium Carbonate Capsules | Batch CA-3160034Mfg Jan 2026 · Exp Jun 2027 | Centurion Remedies Pvt. LtdGujarat | The sample does not conform to Manufacturer Specification with respect to the tests for Uniformity of weight and Assay of Alfacalcidol.Assay | CDL, KolkataCDSCO lab |
| Albendazole Tablets IP 400mg | Batch MT251013Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL, RaipurState lab |
| Albendazole Tablets IP 400 mg | Batch SP250907Mfg Sep 2025 · Exp Aug 2027 | Sharun Pharmaceuticals Pvt.LtdPuducherry | Uniformity of WeightUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab |
| Albendazole Tablets IP 400 mg | Batch SAO-210Mfg Dec 2025 · Exp Nov 2028 | SikkimSikkim | DissolutionDissolution | Lucknow LabState lab |
| Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Batch F9AHY065Mfg Oct 2025 · Exp Sep 2027 | Pharma Force Lab 53-55Himachal Pradesh | Identity test negative for Aceclofenac and Content of ParacetamolOther | Lucknow LabState lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Batch TG25-1919BMfg Oct 2025 · Exp Sep 2027 | Menrik Biomerge Pvt. Ltd. 5Delhi | Content of AceclofenacOther | GORAKHPUR LAB, UPState lab |
| Aceclofenac and Parcetamol IP) | Batch T251733CMfg Sep 2025 · Exp Aug 2027 | Bajaj FormulationsUttarakhand | 01. ASSAY OF ACECLOFENAC I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Aceclofenac Sustained Release and Enteric Coated Rabeprazole Sodium Capsules | Batch C50200BMfg Dec 2025 · Exp Nov 2027 | Samson Laboratories Pvt. LtdHimachal Pradesh | The sample received does not conform to manufacturers specification with respect to the test for Assay of rabeprazole sodium content only.Assay | CDTL, HyderabadCDSCO lab |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets | Batch FND0825055AKMfg Dec 2025 · Exp May 2028 | Ipca Laboratories LtdSikkim | Identity test negative for Aceclofenac and ParacetamolOther | Lucknow LabState lab |
| Aceclofenac & Paracetamol Tablets IP | Batch MT250239Mfg Jun 2025 · Exp May 2028 | Oxford PharmaUttarakhand | Content of Aceclofenac (82.94%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Aceclofenac & Paracetamol Tablets IP | Batch T-2504296Mfg Apr 2025 · Exp Mar 2028 | Gopal LifesciencesHimachal Pradesh | DissolutionDissolution | Lucknow LabState lab |
| Aceclofenac & Paracetamol Tablets | Batch T2601006/AMfg Jan 2026 · Exp Dec 2028 | Empree Medicament India Pvt. Ltd | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab |
| Aceclofenac & Paracetamol Tablets | Batch BLPT-053Mfg Apr 2026 · Exp Mar 2028 | Bonn Stering Bio Science LLPPuducherry | Content of Aceclofenac (81.98%) and Paracetamol (81.62%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Acctaminophen Oral suspension I.P. 125 mg | Batch HL76Mfg Mar 2025 · Exp Feb 2027 | Azine Healthcare Pvt.ltdKerala | Description and Assay for ParacetamolAssay | RDTL. Bellary KarnatakaState lab |
| AZITHROMYCIN ORAL SUSPENSION IP 200 MG/5ML | Batch 41410Mfg Oct 2024 · Exp Sep 2026 | Zenith Drugs Ltd. 72/5 & 72/3Madhya Pradesh | 1. The content of azithromycin in the sample is less(i.e. 65.76% of the labelled amount than the i.p. Limits. 2.Tthe sample is infested with fungus growth. all the observations are done in normal daylight conditions with unaided eyes.4xl5 ml intact brown coloured plastic bottles received for analysis. When opens for analysis, it is observed that in all these 4X15 ML bottles particles are stick around the neck of the bottle. During analysis when the content from these 4x15 ml bottles after shaking transferred individually in clean dry sterilised glass beaker, contains yellow coloured suspension. Yellow coloured suspension which mixes uniformly after shaking.Labelling | FDAL, MumbaiState lab |
| ASPIRIN TABLET IP 75MG | Batch 240968Mfg Sep 2024 · Exp Aug 2027 | Modi AntibioticsGujarat | l]five (5) intact strips often (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2. The content of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab |
| ASPIRIN TABLET IP 75MG | Batch 250168Mfg Jan 2025 · Exp Dec 2027 | Modi AntibioticsGujarat | 1. five (5) intact strips of ten (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2 The co tent of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab |
| ASPIRIN GASTRO- RESISTANT TABLETS I.P. 75 MG | Batch CBT-0254Mfg Oct 2025 · Exp Sep 2027 | Crossasia Biotech Pvt. Ltd. Survery No. 488 A.B. Road Girwai industrial Area Beldarpura Gwalior 474002 (M.P) | Description test for Salicylic Acid Assay for Aspirin and test for DissolutionAssay | RDTL. Bellary KarnatakaState lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Buprenorphine Injection I.P. 2ml | LM1888 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (239 rows). Revised CDSCO lists are diffed on each monthly rebuild.